Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Amputations

September 24, 2019 updated by: Christopher Attinger, M.D., Georgetown University

A Randomized Controlled Trial Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Lower Extremity Amputations: A Pilot Study

The purpose of this study is to evaluate how well subjects heal after surgery who receive standard dressings or incisional negative pressure wound therapy for non-traumatic amputation sites.

Study Overview

Detailed Description

Incisional negative pressure wound therapy is an approved device used for wound healing of closed surgical incisions. This research is being done because incisional negative pressure wound therapy is a new application of negative pressure wound therapy that is applied over a closed incision area instead of an open wound. Negative pressure wound therapy is commonly used to help heal open wounds. It involves the use of a piece of foam, an adhesive drape, and a battery-powered device that places negative pressure on the wound. Currently, there are no trials utilizing incisional negative pressure wound therapy of closed wounds after below knee amputations (BKA), transmetatarsal amputations (TMA), Knee Disarticulations (KD), and Above Knee Amputations (AKA). This is a pilot study that compares incisional negative pressure wound therapy and standard dressings in patients.

Study Type

Interventional

Enrollment (Anticipated)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • District of Columbia
      • Washington, District of Columbia, United States, 20007
        • Recruiting
        • MedStar Georgetown University Hospital
        • Contact:
          • Paul Kim, DPM
          • Phone Number: 202-444-3059
        • Principal Investigator:
          • Paul Kim, DPM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Must be at least 18 years or older to participate.
  2. Requires closure of a nontrauamtic Transmetatarsal Amputation (TMA), Below Knee Amputation (BKA), Knee Disarticulation (KD), or Above Knee Amputation (AKA).
  3. Has at least one artery that feeds the closure site.
  4. Able to comply with clinical trial procedures and schedule.

Exclusion Criteria:

  1. Patients not receiving an amputation.
  2. The investigator/provider determines that the patient has an indication against incisional negative pressure wound therapy that would prevent them from participating.
  3. Surgical incision that is not completely closed.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group A: Standard Dry Dressing
The standard dry dressing is comprised of nonadherent dressing, dry gauze, cotton undercast padding, compression, and immobilization.
These are customary dry dressings.
Active Comparator: Group B: Foam, Drape, and PrevenaTM
This arm is comprised of foam, drape, the PrevenaTM Device, compression, and immobilization.
The PrevenaTM Incision Management System covers and protects the incision from external contamination, while negative pressure removes fluid and infectious material from the surgical incision.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of postoperative incision complications between the 2 arms
Time Frame: 95 days
The proportion of issues that arise between the two groups after closure surgery.
95 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay
Time Frame: 5 days
The amount of time the patients must stay after closure surgery.
5 days
Number of surgically related wound readmissions
Time Frame: 95 days
The number of times patients are readmitted to the hospital for their surgical wound post-discharge.
95 days
Medical Outcomes Study 12 Short Form Health Survey (SF-12)
Time Frame: 95 days
Change in quality of life from the start of the study to the end.
95 days
Percentage of closed incisions remained closed at 1, 2 and 3 months post-hospital discharge
Time Frame: At 1, 2, and 3 months post-hospital discharge
The percentage of closed surgical wounds that remain closed after 1, 2 and 3 months after their closure surgery.
At 1, 2, and 3 months post-hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher Attinger, MD, MedStar Georgetown University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Anticipated)

September 1, 2020

Study Completion (Anticipated)

September 1, 2021

Study Registration Dates

First Submitted

August 8, 2017

First Submitted That Met QC Criteria

August 11, 2017

First Posted (Actual)

August 15, 2017

Study Record Updates

Last Update Posted (Actual)

September 25, 2019

Last Update Submitted That Met QC Criteria

September 24, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017-0599

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on Standard Dry Dressing

Subscribe